MARÍA LUISA
GÓMEZ-LUS CENTELLES
Catedrática de universidad
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (6)
2005
-
Situación de la cefalosporina oral de tercera generación cefditoreno pivoxil en el tratamiento de la infección comunitaria del adulto
Revista Espanola de Quimioterapia, Vol. 18, Núm. 3, pp. 210-216
2004
-
In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin
International Journal of Antimicrobial Agents, Vol. 24, Núm. 1, pp. 79-82
2003
-
Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination
Infection, Vol. 31, Núm. 1, pp. 51-54
2002
-
Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae [1]
International Journal of Antimicrobial Agents
-
Increase of in vitro amoxycillin bactericidal activity by clavulanic acid against Neisseria meningitis using time-kill curves [1]
International Journal of Antimicrobial Agents
2001
-
Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones
Journal of Antimicrobial Chemotherapy, Vol. 48, Núm. 6, pp. 907-909